Comments
Commented by Carsten Mainitz on July 13th, 2022 | 14:32 CEST
Lynas Rare Earths, Defense Metals, Rheinmetall - The arms industry is booming
Since the end of February, a bitter war has been raging in Europe, with currently no end in sight. In the first weeks, attempts were made to stop the war with diplomacy, but this strategy is now off the table. Rearmament is the motto. NATO and its allies are supplying heavy weapons to Ukraine to stop the Russian aggressor. In addition, many Western countries, led by Germany, decided to increase their defense budget in the coming years. The primary beneficiaries of these measures, in addition to the arms corporations, are the producers of rare earth metals.
Read
Commented by André Will-Laudien on July 13th, 2022 | 14:28 CEST
Mercedes-Benz, JinkoSolar and Globex Mining with top news - Nordex needs money again!
Rising commodity prices have recently pushed inflation in Europe to over 7%. With the ongoing conflicts, economic forecasts for global growth are now also clouding over further. The German Federal Bank expects increasing economic risks in the second half of the year and consequently reduced demand for raw materials. As a result, inflation is expected to fall next year due to the high base effects from 2022. The beneficiaries would be the industries currently suffering from fragile supply chains and dependent on a stable supply of raw materials. Hopes are therefore pinned on a near end to the war in Ukraine. Which stocks could then benefit very quickly?
Read
Commented by Fabian Lorenz on July 13th, 2022 | 14:27 CEST
MorphoSys facing a takeover? Exciting autumn ahead for BioNTech and XPhyto
Biotech investors could be in for an exciting autumn. After some sharp price corrections, positive things are happening again in the biotech sector. For one thing, the takeover carousel. It all started in June when Pfizer announced the acquisition of migraine specialist Biohaven for USD 11.6 billion, and GlaxoSmithKline plans to swallow Sierra Oncology for around USD 1.9 billion. Recent deals include the acquisitions of ViaCyte, La Jolla Pharmaceutical and Pliant Therapeutics. MorphoSys is also a possible takeover candidate. It could be a win-win for the German biotech company if the price is attractive. Xphyto could also see at least one investment, as a market-ready product has great potential.
Read
Commented by Stefan Feulner on July 13th, 2022 | 14:23 CEST
Renewable energies on the verge of a comeback - JinkoSolar, dynaCERT, Nel ASA
Despite the statement of the politicians to build renewable energies even faster and on an even larger scale in the future, the corresponding market leaders correct strongly and reduce the admittedly exaggerated valuations of 2020 and 2021. After losses of sometimes more than 50%, hydrogen wind or photovoltaic stocks are becoming interesting again, at least selectively, to be able to outperform one' s portfolio in the coming years.
Read
Commented by Stefan Feulner on July 12th, 2022 | 14:12 CEST
Erin Ventures with multiplication potential, BYD on top, Nordex looking for the bottom
The capital markets are going crazy at the moment. Volatilities are rising on the one hand due to uncertainties regarding fears of recession, and on the other hand, due to worries about too large interest rate jumps. The safe-haven gold is losing more and more value every day, and the euro is heading towards parity. Shares in future technologies, the construction of which is expected to be significantly accelerated by Russia's invasion, also continue to be in correction mode. However, opportunities lurk here, especially in the long term, which can significantly outperform the market.
Read
Commented by Nico Popp on July 12th, 2022 | 14:09 CEST
Waiting is not an option! BioNTech, MAS Gold, BASF
Inflation is rising and rising. In construction, inflation has already reached almost 20%. Even in everyday life, double-digit inflation rates are not far away. At the same time, infection figures are rising, and it is still uncertain whether gas will flow through Nord Stream 1 again in the coming weeks. Given this mixed situation, many investors are asking how they should invest. Because one thing is clear: waiting is not an option - the real return on many asset classes is clearly negative. We take a look at three stocks and check their future prospects.
Read
Commented by Armin Schulz on July 11th, 2022 | 15:35 CEST
BYD, First Hydrogen, Amazon - Electric vehicles on the brink of extinction?
Alongside industry leader Tesla, Chinese carmakers, in particular, have been early adopters of e-cars. Since the end of the internal combustion engine was decided, there has been a battle for the one emission-free drive. For a long time, electromobility seemed to be winning the race, but charging times are still too long and ranges are limited. These are important factors, especially in the logistics sector. Now the first series production of hydrogen cars is starting in China. Changan Automobile, founded in 1862, claims a range of 700km for its hydrogen cars with a refueling time of a few seconds. Is this the beginning of the end for electric vehicles?
Read
Commented by Stefan Feulner on July 11th, 2022 | 15:33 CEST
Easing at BioNTech and BASF, and Almonty Industries with a clear signal
Concerns about the onset of a global recession are increasing dramatically, as shown by the economic data published last week. As a result, almost all asset classes corrected, and the fluctuation range increased enormously. In addition to the stock markets, which have been in a correction for months, crypto and precious metals prices also fell sharply. Even the oil price, which has been booming due to the Russian sanctions, was dragged down. At current levels, however, attractive, anti-cyclical entry opportunities are emerging.
Read
Commented by André Will-Laudien on July 11th, 2022 | 15:32 CEST
Take advantage of the crash in these stocks: Infineon, Siemens, BrainChip and Apple in focus!
High-tech, cars, household appliances, smartphones, renewables - the list of products seems endless. What they all have in common is the need for smart chips: But the effects of the global chip shortage are omnipresent. From today's perspective, leaders would undoubtedly like to turn globalization back a bit because the relocation of production sites around the world is creating huge problems ranging from logistics to high procurement prices to completely destroyed supply chains. If Central Europe does not grasp its energy dependence on the East soon, hard times may lie ahead for local industrial locations. Where are the opportunities in a fragile environment?
Read
Commented by Nico Popp on July 11th, 2022 | 15:29 CEST
What if everything turns out well? Nordex, Aspermont, Deutsche Bank
The R-word is currently doing the rounds - and is playing a major role in ensuring that the downward economic spiral accelerates even faster. Yet the US economy is still doing well. Although economic data always refers to the past, the purchasing managers' index and labor market data speak a clear language. A recession looks different. But why is the stock market sky still not full of violins after last week's correction? We take three stocks as examples and do the comeback check for the stock market.
Read